Connect with us

Hi, what are you looking for?

Jewish Business News

Health New Researches

New Global Study Reveals Key Biomarkers for All Five Clinical Stages of Parkinson’s Disease

By creating a new metric, researchers envision the possibility of diagnostic and treatment advances for the disease, which is estimated to affect about 4 million people worldwide

Parkinson’s

In a pioneering study spanning 20 countries and analyzing brain images from over 2,500 people with Parkinson’s disease, scientists have uncovered critical patterns of neurodegeneration, mapping the disease’s progression with unprecedented precision.

Published in NPJ Parkinson’s Disease, this research marks a major leap forward in understanding Parkinson’s at every stage. By developing quantifiable metrics for each of the five clinical stages, researchers have laid the foundation for transformative breakthroughs—not only in early and accurate diagnosis but also in revolutionizing treatment development and monitoring. This vast dataset opens the door to a future where new therapies can be tested and refined with greater accuracy than ever before, offering hope to millions worldwide.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.

Affecting an estimated 4 million individuals worldwide, Parkinson’s disease is a debilitating neurological condition that gradually impairs movement. Starting with unilateral tremors and stiffness, the disease progresses over potentially two decades, eventually leading to bilateral symptoms and, in advanced stages, reliance on a wheelchair due to leg rigidity.

“We observed that as each stage of the disease progressed, there was a greater degree of atrophy or hypertrophy not only in the movement-related structures but also in other cortical areas. And it’s these combinations of atrophy and hypertrophy that are related to the stage of the disease,” Fernando Cendes, senior researcher at the Brazilian Research Institute for Neuroscience and Neurotechnology (BRAINN) explains.

“But that’s not all we observed, some of these structures also had differences in shape. They had changed their spatial configuration. Some regions of the thalamus [a structure whose function is to relay information from the senses to the cerebral cortex] had become thicker. Other regions, such as the amygdalae [which play a role in regulating social behavior and emotions] had atrophied,” he notes.

The researcher explains that these changes cannot be seen with the naked eye: “They’re submillimetric measurements. However, with programs and the use of artificial intelligence, it’s possible to identify patterns and, in the future, monitor these changes,” he says.

Newsletter



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Life-Style Health

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Religion

He hopes to be a real Jew in time for Passover.

Leadership

Jews are disproportionately represented on the roster of the richest business people, with 10 Jews among the top 50 (20%), and 38 (19%) Jews...